Navigation Links
PercSys Introduces Accordion CoAx(TM) Stone Control Device for Facilitating Percutaneous Kidney Stone Treatments
Date:4/23/2009

PALO ALTO, Calif., April 23 /PRNewswire/ -- Percutaneous Systems, Inc. (PercSys) today announced that it will introduce the Accordion CoAx(TM) Stone Control Device, the newest member of its Accordion family of disposable kidney stone treatment tools, at the upcoming annual meeting of the American Urological Association (AUA), to be held April 25-28 in Chicago, Illinois.

The Accordion CoAx Stone Control Device is an over-the-wire stone management device designed to simplify and shorten minimally invasive percutaneous kidney stone procedures, called percutaneous nephrolithotomy (PCNL). A method of stone removal that involves passing small endoscopic instruments through the skin into the kidney, PCNL is the treatment of choice for patients with large kidney stones or for those with complex, irregularly shaped "staghorn" stones.

During the PCNL procedure, the Accordion CoAx Stone Control Device is deployed in the upper portion of the ureter, a tube that carries urine from the kidney to the bladder. The low-profile Accordion CoAx device is placed over a guidewire, and once in position, forms a proprietary multi-fold, 15 millimeter diameter film occlusion that conforms to and fills the ureter in order to prevent the migration of stone fragments further down in the ureter during the fragmentation procedure. In this way, the CoAx device can eliminate or minimize the need for an additional procedure.

"The Accordion CoAx Stone Control Device combines the benefits of the original PercSys Accordion device with the versatility of an over-the-wire design," said Mantu Gupta MD, Director of the New York-Presbyterian Kidney Stone Center and the Director of Endourology, New York Presbyterian Hospital/Columbia University, New York, NY. "Optimized for PCNL procedures, the new CoAx device builds on the original Accordion platform, which has been clinically proven to reduce procedural time and decrease morbidity during PCNL treatments at our institution."

"We have found the Accordion CoAx Stone Control Device to be a valuable tool during PCNL procedures, as it both facilitates retrograde contrast injections for diagnosis and renal targeting as well as prevents antegrade fragment migration into the ureter," said Demetrius H. Bagley MD, Nathan Lewis Hatfield Professor of Urology, Thomas Jefferson University Hospital, Philadelphia, PA. "Unlike other catheters used for this purpose, the Accordion CoAx device, thanks to its occlusion-film design, does not move from the treatment location despite the patient handling inherent in PCNL procedures."

The Accordion CoAx Stone Control Device joins the currently available 7mm and 10mm PercSys Accordion(R) Stone Management Devices, which are used during ureteroscopic lithotripsy procedures to prevent the retrograde migration of stone fragments into the kidney. The 7mm and 10mm Accordion Stone Management Devices have been used in nearly 1,400 procedures since their introduction in 2007 and 2008, respectively.

About Kidney Stones

Approximately 1.7 million people in the U.S. experience kidney stones each year. Half of those will have at least one recurrence during their lifetime. One in four will find it necessary to undergo endoscopic lithotripsy (PCNL or ureteroscopic stone treatment). Once primarily a male affliction, kidney stone disease is increasingly affecting women, who now constitute two of every five cases diagnosed.

About PercSys

PercSys is a medical device company focused on providing a suite of single-use tools to improve every type of kidney/ureteral stone treatment in every location within the urinary tract. The company's goal is to make endourologic kidney stone procedures easier, less traumatic, and more effective therapeutically. PercSys currently markets the 7 and 10mm PercSys Accordion Stone Management Devices and will commercially launch the Accordion CoAx Stone Control Device in mid-2009. In addition to providing devices for procedures in the operating room, the company is developing additional products and techniques for both external shock-wave stone treatments and for office-based stone interventions. For more information, contact PercSys at 1-650-493-4200, or visit its website at www.percsys.com.

Note: Product photo available upon request.


'/>"/>
SOURCE PercSys
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lumenis Introduces the HoLEP Simulator and the PolyScope Disposable Ureteroscope at American Urology Association 2009 Annual Meeting
2. Medstrat Introduces Depots!
3. SynCardia Introduces New 12-lb Freedom Discharge Driver Designed to Provide Quality 'Lifestyle' for Total Artificial Heart Patients
4. The ASDS Introduces the First At-Home Skin Cancer Exam Kit
5. AMD LASERS(TM) Introduces the Picasso Diode Laser
6. Amoena Introduces First Post Surgical Garments With Vitamin E & Aloe to Help Soothe and Comfort After Breast Surgery
7. Blue Cross and Blue Shield of Florida Introduces BlueMedicare(SM) Group Supplement
8. Passlogix Introduces Industry's Fastest Sign-On to Kiosks with New Enhancements to v-GO Session Manager
9. Sentillion Introduces Advanced Authentication Solution For Direct Access to Cerner, Eclipsys, Epic, McKesson and MEDITECH Applications
10. Vinpower Digital Introduces Series of Standalone 8X Blu-ray Disc Duplicators with LightScribe Printing Capability
11. Allscripts Introduces SaaS Solution for Prenatal Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology: